Literature DB >> 18801070

Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse.

Etsuko Fujii1, Masami Suzuki, Koichi Matsubara, Miho Watanabe, Yu Jau Chen, Kenji Adachi, Yasuyuki Ohnishi, Manabu Tanigawa, Masayuki Tsuchiya, Norikazu Tamaoki.   

Abstract

Immunodeficient mice are widely used for xenografts of human cells and tissue. The purpose of the present study was to investigate the characteristics of xenograft human tumor models using engraftment of various non-hematopoietic tumors in the NOD/SCID/gamma(c) (null) mouse. For tumor models, human solid tumor tissues were serially passaged three or more times to establish tissue lines. A total of 326 fresh tumor specimens, mainly gastrointestinal and female genital tissue, were engrafted with 54 established tissue lines. The types of tissue lines varied and included tumor tissue of both epithelial and mesenchymal origin. In some cases the original surgical specimen was replaced with large mononuclear cells. In the established tumor tissue lines, differentiation and tumor structure were similar to that of the original surgical specimen. The interstitium of the xenograft tissue in the tissue lines was relatively well preserved although slightly decreased and replaced by host tissue. These results indicate that human solid tumors can be successfully engrafted into the NOD/SCID/gamma(c) (null) mouse and that tissue lines with the characteristics of the original tumors can be established. Investigators in the field of tumor research will benefit from the availability of tissue lines that allow the establishment of more relevant in vivo human tissue models.

Entities:  

Mesh:

Year:  2008        PMID: 18801070     DOI: 10.1111/j.1440-1827.2008.02271.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  17 in total

1.  Recombinant adenoviral vector expressing human wild-type p53, GM-CSF, and B7-1 genes suppresses the growth of glioma in vivo.

Authors:  Sizhe Feng; Song Han; Dongsheng Pan; Mingpei Liu; Xinli Feng; Tao Dong; Wei Li; Xuezhong Wei
Journal:  Tumour Biol       Date:  2014-01-10

2.  Establishment of NOD/SCID mouse models of human hepatocellular carcinoma via subcutaneous transplantation of histologically intact tumor tissue.

Authors:  Mingxia Yan; Hong Li; Fangyu Zhao; Lixing Zhang; Chao Ge; Ming Yao; Jinjun Li
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

3.  Cryopreservation of human colorectal carcinomas prior to xenografting.

Authors:  Michael Linnebacher; Claudia Maletzki; Christiane Ostwald; Ulrike Klier; Mathias Krohn; Ernst Klar; Friedrich Prall
Journal:  BMC Cancer       Date:  2010-07-08       Impact factor: 4.430

4.  Establishment of experimental implantation tumor models of hepatocellular carcinoma in Wistar rats.

Authors:  Yi Jin; Dayue Tong; Junjie Shen; Jianyong Yang; Jiaping Li
Journal:  Tumour Biol       Date:  2014-06-07

5.  Ex-vivo clonally expanded B lymphocytes infiltrating colorectal carcinoma are of mature immunophenotype and produce functional IgG.

Authors:  Claudia Maletzki; Annika Jahnke; Christiane Ostwald; Ernst Klar; Friedrich Prall; Michael Linnebacher
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

6.  The status of donor cancer tissues affects the fate of patient-derived colorectal cancer xenografts in NOG mice.

Authors:  Etsuko Fujii; Atsuhiko Kato; Yu Jau Chen; Koichi Matsubara; Yasuyuki Ohnishi; Masami Suzuki
Journal:  Exp Anim       Date:  2015-01-26

7.  Establishment of patient-derived cancer xenografts in immunodeficient NOG mice.

Authors:  Tsuyoshi Chijiwa; Kenji Kawai; Akira Noguchi; Hidemitsu Sato; Akimune Hayashi; Haruhiko Cho; Manabu Shiozawa; Takeshi Kishida; Soichiro Morinaga; Tomoyuki Yokose; Makoto Katayama; Nobuo Takenaka; Hiroshi Suemizu; Roppei Yamada; Yoshiyasu Nakamura; Takashi Ohtsu; Yasuo Takano; Kohzoh Imai; Yohei Miyagi; Masato Nakamura
Journal:  Int J Oncol       Date:  2015-05-11       Impact factor: 5.650

8.  Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer.

Authors:  Yoon Young Choi; Jae Eun Lee; Hyunki Kim; Moon Hee Sim; Ka-Kyung Kim; Gunho Lee; Hyoung-Il Kim; Ji Yeong An; Woo Jin Hyung; Choong-Bai Kim; Sung Hoon Noh; Sangwoo Kim; Jae-Ho Cheong
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

9.  Tumor Take Rate Optimization for Colorectal Carcinoma Patient-Derived Xenograft Models.

Authors:  Michael Gock; Florian Kühn; Christina Susanne Mullins; Mathias Krohn; Friedrich Prall; Ernst Klar; Michael Linnebacher
Journal:  Biomed Res Int       Date:  2016-11-23       Impact factor: 3.411

10.  Characterization of EBV-related lymphoproliferative lesions arising in donor lymphocytes of transplanted human tumor tissues in the NOG mouse.

Authors:  Etsuko Fujii; Atsuhiko Kato; Yu Jau Chen; Koichi Matsubara; Yasuyuki Ohnishi; Masami Suzuki
Journal:  Exp Anim       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.